Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,252 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,462
Recruiting: 819
Ph III recruiting: 96
Growth YoY: +6%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 1–50 of 230 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06353061	Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer	unknown	Phase 2	51	Peking Union Medical College HospitalOTHER	1	Jan 14, 2025	clinicaltrials
NCT06237257	A Study of Chemoradiotherapy With SHR-1316 For Treatment of Locally Advanced Cervical Cancer	unknown	Phase 2	56	Shanghai Shengdi Pharmaceutical Co., LtdINDUSTRY	1	Dec 24, 2024	clinicaltrials